vimarsana.com
Home
Live Updates
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2023 Earnings Call Transcript : vimarsana.com
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2023 Earnings Call Transcript
Matthew Scalo: Okay. Good afternoon, and welcome to the Myriad Genetics' First Quarter 2023 Earnings Call. During the call, we will review the financial results we released today.
Related Keywords
California ,
United States ,
South San Francisco ,
Salt Lake City ,
Utah ,
Salt Lake ,
America ,
Matthew Scalo ,
Mark Verratti ,
Mason Carrico ,
Puneet Souda ,
Nicole Lambert ,
Paul Diaz ,
Walter Gilbert ,
Bryan Riggsbee ,
Andrew Cooper ,
Mychoice Cdx ,
Dave Delahunt ,
Jack Meehan ,
Raymond James ,
Matt Scalo ,
Exchange Commission ,
Nephron Research ,
Goldman Sachs ,
Innovation Center ,
Genetics Inc ,
Nasdaq ,
Walter Gilbert Research ,
Myriad Genetics ,
Call Transcript May ,
Myriad Genetic First Quarter ,
Senior Vice President ,
Chief Executive Officer ,
Chief Financial Officer ,
Chief Operating Officer ,
Chief Commercial ,
Simonmed Imaging ,
Chief Commercial Officer ,
Net Promoter Score ,
Gateway Genomics ,
Precise Tumor ,
Nobel Prize ,
Investor Relations ,
Myriad Genetics Inc ,
Derik De Bruin ,
vimarsana.com © 2020. All Rights Reserved.